Paper9836772
Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia.
Belayev L and 7 others. Stroke, 1998. Cited by 136 papers, by iCite.
Cite this record
ConductScience Library. Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia. Papers, record 9836772. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9836772
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Ischemia | Major topic |
| Magnetic Resonance Imaging | Major topic |
| Neuroprotective Agents | Major topic |
| Serum Albumin | Major topic |
| Animals | |
| Brain | |
| Brain Edema | |
| Diffusion | |
| Endothelium, Vascular | |
| Humans | |
| Male | |
| Microglia | |
| Rats | |
| Rats, Sprague-Dawley |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| NS05820 | NINDS NIH HHS | United States | P01NS005820 | PubMed and NIH | NIH RePORTER |
| P50NS005820 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 12511738 | Beneficial effect of albumin therapy attributable to alpha1-acid glycoprotein? | https://conductscience.org/library/papers/12511738 |
Source PubMed
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42156639 | Intra-Arterial Selective Hypothermic Human Serum Albumin Perfusion Attenuates Cerebral Ischemia-Reperfusion Injury. | Transl Stroke Res | 2026 | https://conductscience.org/library/papers/42156639 | PubMed |
| 42010254 | Efficacy and safety of albumin combined with endovascular therapy in the treatment of patients with acute ischemic stroke: a randomized clinical trial. | Nat Commun | 2026 | https://conductscience.org/library/papers/42010254 | PubMed |
| 41468394 | Early combination of albumin with crystalloids administration might not be beneficial for the survival of ischemic stroke patients with sepsis: A retrospective analysis from MIMIC‑IV database. | PLoS One | 2025 | https://conductscience.org/library/papers/41468394 | PubMed |
| 41003011 | Essential Amino Acid Supplementation May Attenuate Systemic Inflammation and Improve Hypoalbuminemia in Subacute Hemiplegic Stroke Patients. | Metabolites | 2025 | https://conductscience.org/library/papers/41003011 | PubMed |
| 40944047 | A Comprehensive Review of Fluid Resuscitation Strategies in Traumatic Brain Injury. | J Clin Med | 2025 | https://conductscience.org/library/papers/40944047 | PubMed |
| 40757028 | Albumin for patients with acute large-vessel occlusive stroke undergoing endovascular therapy (ARISE): the protocol of a randomized double-blind trial. | Front Neurol | 2025 | https://conductscience.org/library/papers/40757028 | PubMed |
| 39403266 | Albumin adjuvant therapy for acute ischemic stroke with large vessel occlusion (AMASS-LVO): rationale, design, and protocol for a phase 1, open-label, clinical trial. | Front Neurol | 2024 | https://conductscience.org/library/papers/39403266 | PubMed |
| 38192834 | Acute albumin administration as therapy for intracerebral hemorrhage: A literature review. | Heliyon | 2024 | https://conductscience.org/library/papers/38192834 | PubMed |
| 36969491 | Correlation Analysis of Neutrophil/Albumin Ratio and Leukocyte Count/Albumin Ratio with Ischemic Stroke Severity. | Cardiol Cardiovasc Med | 2023 | https://conductscience.org/library/papers/36969491 | PubMed |
| 35544482 | Optimizing acute stroke outcome prediction models: Comparison of generalized regression neural networks and logistic regressions. | PLoS One | 2022 | https://conductscience.org/library/papers/35544482 | PubMed |
| 33959442 | Frequency of Hypoalbuminemia and In-Hospital Mortality in Acute Ischemic Stroke Patients Presenting at a Tertiary Care Hospital, Hyderabad. | Cureus | 2021 | https://conductscience.org/library/papers/33959442 | PubMed |
| 33945037 | Albumin therapy for acute ischemic stroke: a meta-analysis. | Neurol Sci | 2021 | https://conductscience.org/library/papers/33945037 | PubMed |
| 33599834 | Investigation of brain damage mechanism in middle cerebral artery occlusion/reperfusion rats based on i-TRAQ quantitative proteomics. | Exp Brain Res | 2021 | https://conductscience.org/library/papers/33599834 | PubMed |
| 31565439 | Prognostic Value of Serum Albumin at Admission for Neurologic Outcome with Targeted Temperature Management after Cardiac Arrest. | Emerg Med Int | 2019 | https://conductscience.org/library/papers/31565439 | PubMed |
| 31412042 | The relationship between plasma amino acids and circulating albumin and haemoglobin in postabsorptive stroke patients. | PLoS One | 2019 | https://conductscience.org/library/papers/31412042 | PubMed |
| 30746015 | Serum Albumin as a Predictor of Functional Outcomes Following Acute Ischemic Stroke. | J Vasc Interv Neurol | 2018 | https://conductscience.org/library/papers/30746015 | PubMed |
| 28794441 | TGFβ signaling is associated with changes in inflammatory gene expression and perineuronal net degradation around inhibitory neurons following various neurological insults. | Sci Rep | 2017 | https://conductscience.org/library/papers/28794441 | PubMed |
| 28680300 | Repeated Oral Administration of Human Serum Albumin Protects from the Cerebral Ischemia in Rat Brain Following MCAO. | Exp Neurobiol | 2017 | https://conductscience.org/library/papers/28680300 | PubMed |
| 28598225 | A novel voxel-wise lesion segmentation technique on 3.0-T diffusion MRI of hyperacute focal cerebral ischemia at 1 h after permanent MCAO in rats. | J Cereb Blood Flow Metab | 2018 | https://conductscience.org/library/papers/28598225 | PubMed |
| 28586018 | Transient cerebral ischemia induces albumin expression in microglia only in the CA1 region of the gerbil hippocampus. | Mol Med Rep | 2017 | https://conductscience.org/library/papers/28586018 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9836772
GET https://conductscience.org/api/papers/v1/9836772/cited_by?page=2